Strategies for Treatment-Resistant Depression
By Christos Ballas, MD, Jeffrey P. Staab, MD, MS, and Dwight L. Evans, MD
Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety
By Philip T. Ninan, MD, Sarah A. Feigon, PhD, and Bettina Knight, RN
New Advances in the Management of Anxiety Disorders
By Mark H. Pollack, MD
Gender-Specific Differences in Depression and Treatment Response
By Susan G. Kornstein, MD, Diane M. E. Sloan, PharmD, and Michael E. Thase, MD
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
By Charles B. Nemeroff, MD, PhD
Neuropharmacology of Paroxetine
By Michael J. Owens, PhD, and Charles B. Nemeroff, MD, PhD
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
By Clinton Kilts, PhD
Paroxetine Treatment of Major Depressive Disorder
By Martin B. Keller, MD
Treatment of Panic Disorder: Focus on Paroxetine
By Mark H. Pollack, MD and Alicia C. Doyle, BA
Paroxetine Treatment of Generalized Anxiety Disorder
By David V. Sheehan, MD, MBA, and C. Gloria Mao, PharmD
Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine
By Jonathan R.T. Davidson, MD
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
By Philip T. Ninan, MD
Advances in Recognition and Treatment of Social Anxiety Disorder: A 10-Year Retrospective
By Murray B. Stein, MD, FRCPC
Paroxetine Use in Medically Ill Patients
By Steven Stout, MD, PhD, Wendy I. Somerset, MD, Andrew Miller, MD, and Dominique L. Musselman, MD, MS
Paroxetine Treatment of Depression in Late Life
By Charles F. Reynolds III, MD
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
By Kimberly A. Yonkers, MD
Clinical Management of Perinatal Depression: Focus on Paroxetine
By D. Jeffrey Newport, MD, MSCR, MDiv, and Zachary N. Stowe, MD
Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents
By Karen Dineen Wagner, MD, PhD
Pharmacology of Valproate
Divalproex and Epilepsy
By L. James Willmore, MD
The Efficacy of Divalproex for Partial Epilepsies
By Michael C. Smith, MD
Divalproex in the Treatment of Bipolar Disorder
By Paul E. Keck, Jr, MD, and Susan L. McElroy, MD
Schizophrenia and Valproate
By Leslie Citrome, MD, MPH
The Use of Divalproex in the Treatment of Addictive Disorders
By Hugh Myrick, MD and Kathleen T. Brady, MD, PhD
Divalproex in the Treatment of Migraine
By Frederick G. Freitag, DO
Valproate Use in Neuropsychiatric Disorders in the Elderly
By Pierre N. Tariot, MD
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
Studying Non-Human Primates: A Gateway to Understanding Anxiety Disorders
By Ned H. Kalin, MD
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
Understanding Psychiatric Disorders Through Functional Brain Imaging
By Clinton D. Kilts, PhD
Late-Life Anxiety Disorders
By Carl Salzman, MD
Unmet Needs in the Treatment of Anxiety Disorders
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
Panel Discussion
Evidence-Based Treatment of Psychiatric Disorders with Comorbid Medical Illnesses: The Need for Large Simple Clinical Trials
Warren D. Taylor, MD, P. Murali Doraiswamy, M.B.,B.S., and K. Ranga R. Krishnan, M.B.,B.S
Invited Commentary: Understanding the Fibromyalgia Syndrome
I. Jon Russell, MD, PhD. and Christopher J. Wohlberg, MD, PhD
Psychosocial Interventions for Bipolar Disorder: A Review of Literature and Introduction of the Systematic Treatment Enhancement Program
David J. Miklowitz, PhD and Michael W. Otto, PhD
Genetics and Its Use in Alzheimer’s Disease
Joseph H. Lee, DRPH and Richard Mayeux, MD, MSC
Ethical Issues in Schizophrenia: Considerations for Treatment and Research
By Laura B. Dunn, MD
Neuropsychiatric Update: Neuroimaging Schizophrenia
By Shawn J. Kile, MD
Genetics of Schizophrenia: Recent Advances
By Amy Eisener, BS, Michele T. Pato, MD, Helena Medeiros, MSW, Celia Carvalho, MS, and Carlos N. Pato, MD
Primary Sexual Disorders: Recognition and Treatment
By Paula L. Hensley, MD, and Carol K. Slonimski, PhD